1Ford ES.Prevalence of metabolic syndrome defined by the international diabetes federation among adults in the US[J].Diabetes Care,2005,28:2745-2749.
2Ford ES,Giles WH,Dietz WH.Prevalence of the metabolic syndrome among US adults:Findings from the third National Health and Nutrition Examination Survey[J].JAMA 2002,287:356-359.
3Solymossa BC,Bourassaa MG,Lespreancea J,et al.Incidence and clinical characteristics of metabolic syndrome in patients with coronary disease[J].Coronary Artery Disease,2003,14(3):207-212.
4Miller DD.Review and management of clozapine side effects[J].J Clin Psychiatry,2000,61(suppl8):14-17.
9Kitabayashi Y,Narumoto J,Kitabayashi M,et al.Body mass index among Japanese in patients with schizophrenia[J].Int J Psychiatry Med,2006,36(1):93-102.
10Hellerstein DJ,Almeida G,Devlin MJ,et al.Assessiny obesity and other related health problems of mentally ill hispanic patiences in an urban outpatients stting[J].Psychiatry Q,2007,78(3):171-181.
二级参考文献10
1[1]Ford ES.Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US[J].Diabetes Care,2005,28:2745-2749
3[3]McGarry JD.Dysfunction of fatty acid metabolism in the etiology of type 2 diabetes[J].Diabetes,2002,51:7-18
4[4]Newcomer JW.Metabolic considerations in the use of antipsychotic medications:a review of recent evidence[J].J Clin Psychiatry,2007,68 Suppl:20-27
5[5]Kitabayashi Y,Narumoto J,Kitabayashi M,et al.Body mass index among Japanese inpatients with schizophrenia[J].Int J Psychiatry Med,2006,36(1):93-102
6[6]Hellerstein DJ,Almeida G,Devlin MJ,et al.Assessing Obesity and Other Related Health Problems of Mentally Ⅲ Hispanic Patients in an Urban Outpatient Setting[J].Psychiatr Q,2007,78(3):171-181
7[7]Bobes J,Arango C,Aranda P,et al.Cardiovascular and metabolic risk in outpatients with schizophrenia trcatcd with antipsychotics:results of the CLAMORS Study[J].Schizophr Res,2007,90(1-3):162-173
8[8]McEvoy J.P..Meyer J.M.,Golf D.C.,et al.Prevalence of the metabolic syndrome in patients with schizophrenia:bascline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES Ⅲ[J].Schizophr Res,2005,80:19-32
9[9]Meyer J,Nasrallah H.A,McEvoy J.P,et al.The Clinical Antipsychotic Trials of Intervention Effectivcncss (CATIE) Schizophrenia Trial:clinical comparison of subgroups with and without the metabolic syndrome[J].Schizophr Res,2005,80:9-18
10[10]Hakko H,Komulainen MT,Koponen H,et al.Are females at special risk of obesity if they become psychotic?The longitudinal Northern Finland 1966 Birth Cohort Study[J].Schizophr Res,2006,84(1):15-19
